Evidence map›Paper›PMID 32762385›Full record

ArticleThe Journal of international medical research2020

Drug-coated balloons used in peripheral artery disease: experience from a single center.

Jinbo Liu, Tianrun Li, Wei Huang, Na Zhao, Huan Liu, Hongwei Zhao, Jiufeng Xu, Hongyu Wang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of international medical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jinbo LiuDepartment of Vascular Medicine, Peking University Shougang Hospital, Beijing, P. R. of China.ORCID https://orcid.org/0000-0003-1297-2176
Tianrun LiDepartment of Interventional Vascular Surgery, Peking University Third Hospital, Beijing, P. R. of China.
Wei HuangDepartment of Vascular Medicine, Peking University Shougang Hospital, Beijing, P. R. of China.
Na ZhaoDepartment of Vascular Medicine, Peking University Shougang Hospital, Beijing, P. R. of China.
Huan LiuDepartment of Vascular Medicine, Peking University Shougang Hospital, Beijing, P. R. of China.
Hongwei ZhaoDepartment of Vascular Medicine, Peking University Shougang Hospital, Beijing, P. R. of China.
Jiufeng XuDepartment of Orthopedics, Peking University Third Hospital Yanqing Hospital, Beijing, P. R. of China.
Hongyu WangDepartment of Vascular Medicine, Peking University Shougang Hospital, Beijing, P. R. of China.
Peking University Shougang Hospital · CNPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis retrospective single-center study aimed to analyze immediate and follow-up results of using drug-coated balloons (DCBs) for treating peripheral arterial disease.

methodsIn this study, we identified a total of 75 patients who underwent DCB therapy at our institution. The ankle-brachial index (ABI) was measured before and after intervention. Intermittent claudication and whether there was healing of ulcers were determined by telephone.

resultsThe cohort consisted of 56 men and 19 women aged 38 to 87 years (68 ± 12 years). Twenty-three patients had Rutherford grade III, 15 had Rutherford grade IV, and 37 had Rutherford grade V. Seventeen patients had stents and 18 had the Rotarex system used. The postoperative ABI was significantly greater than the preoperative ABI (0.911 ± 0.173 vs 0.686 ± 0.249). Good results for treatment were obtained. Intermittent claudication and rest pain did not occur in subjects with Rutherford grades III and IV during follow-up. The amputation rate was 4.1% among all patients using DCB therapy during follow-up.

conclusionsDCB therapy is safe and effective for treating peripheral arterial disease in real-world patients. Future prospective studies on this issue are recommended.

Indexed as

Angioplasty, BalloonCardiovascular AgentsPeripheral Arterial DiseasePharmaceutical PreparationsVascular Access DevicesAdultAgedAged, 80 and overCoated Materials, BiocompatibleFemaleFemoral ArteryHumansMaleMiddle AgedPopliteal ArteryProspective StudiesCardiovascular AgentsCoated Materials, BiocompatiblePharmaceutical Preparationsamputationankle–brachial indexDrug-coated balloonperipheral arterial diseaseRotarex systemRutherford grade

Identifiers

PMID32762385
PMCPMC7416143
OpenAlexW3048125713

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.